ACH

MKT CAP:$250M

Accendra Health, Inc.

Market Cap

$250M

Healthcare·Medical - Distribution·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$3.30+$0.98 (+42.24%)

Apr 24, 2026

Company Details

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment...

CEO

Edward A. Pesicka

IPO Date

Mar 17, 1980

Website

www.owens-minor.com

Key Metrics TTM

Revenue

$6.7B

-21.2% YoY

Net Income

-$484M

EPS (Diluted)

-$6.27

Free Cash Flow

-$356M

Revenue / Share

$86.85

Gross Margin

26.2%

Operating Margin

-3.0%

Net Margin

-7.2%

FCF Margin

-5.3%

P/S

0.0x

P/E

—

Earnings Reports

Q4 2025

May 14, 2026

PENDING

FY 2025

Oct 30, 2025

$3.3B-50.0%EPS -$2.26

Q3 2025

Oct 30, 2025

$697M+1.5%EPS -$1.94

Q1 2025

May 8, 2025

$2.6B+0.7%EPS -$0.32

FY 2024

Feb 28, 2025

$6.7B-35.6%EPS -$4.72

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$2.5B	$329M	$63M
Q4 21	$2.5B	$342M	$62M
Q1 22	$2.4B	$373M	$61M
Q2 22	$2.5B	$533M	$75M
Q3 22	$2.5B	$513M	$60M
Q4 22	$2.6B	$407M	-$53M
Q1 23	$2.5B	$497M	$10M
Q2 23	$2.6B	$519M	$11M
Q3 23	$2.6B	$538M	$24M
Q4 23	$2.7B	$570M	$60M
Q1 24	$2.6B	$536M	$10M
Q2 24	$660M	$316M	$17M
Q3 24	$687M	$332M	$31M
Q4 24	$2.7B	$580M	-$262M
Q1 25	$2.6B	$526M	$124.0K
Q3 25	$697M	$322M	$26M

Valuation

Quarter	P/S	P/E
Q3 21	0.2x	10.0x
Q4 21	0.3x	14.8x
Q1 22	0.3x	17.1x
Q2 22	0.3x	16.0x
Q3 22	0.2x	14.9x
Q4 22	0.2x	66.7x
Q1 23	0.1x	—
Q2 23	0.1x	—
Q3 23	0.1x	—
Q4 23	0.1x	—
Q1 24	0.2x	—
Q2 24	0.1x	—
Q3 24	0.2x	—
Q4 24	0.1x	—
Q1 25	0.1x	—
Q3 25	0.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	$61M	$47M
Q4 21	$50M	$33M
Q1 22	$80M	$69M
Q2 22	$90M	$35M
Q3 22	$69M	$19M
Q4 22	$87M	$36M
Q1 23	$158M	$107M
Q2 23	$313M	$264M
Q3 23	$157M	$107M
Q4 23	$112M	$55M
Q1 24	-$53M	-$102M
Q2 24	$116M	$70M
Q3 24	$27M	-$34M
Q4 24	$71M	$8M
Q1 25	-$35M	-$100M
Q3 25	-$173M	-$230M

Capital Expenditures

Quarter	CapEx
Q3 21	$14M
Q4 21	$17M
Q1 22	$11M
Q2 22	$55M
Q3 22	$49M
Q4 22	$51M
Q1 23	$51M
Q2 23	$49M
Q3 23	$51M
Q4 23	$56M
Q1 24	$49M
Q2 24	$46M
Q3 24	$62M
Q4 24	$63M
Q1 25	$65M
Q3 25	$58M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	+14.4%	+15.5%
Q4 21	+4.5%	+6.1%
Q1 22	+3.5%	+7.6%
Q2 22	+0.4%	+1.4%
Q3 22	-0.2%	-0.1%
Q4 22	+3.4%	+8.3%
Q1 23	+4.8%	+7.1%
Q2 23	+2.5%	+5.3%
Q3 23	+3.8%	+5.4%
Q4 23	+4.1%	-0.3%
Q1 24	+3.6%	+3.6%
Q2 24	-74.2%	-74.8%
Q3 24	-73.5%	-74.5%
Q4 24	+1.5%	+13.9%
Q1 25	+0.7%	+1.1%
Q3 25	+5.6%	+4.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$6M	0.2%
Q4 21	$6M	0.2%
Q1 22	$5M	0.2%
Q2 22	$6M	0.2%
Q3 22	$5M	0.2%
Q4 22	$5M	0.2%
Q1 23	$6M	0.3%
Q2 23	$5M	0.2%
Q3 23	$6M	0.2%
Q4 23	$6M	0.2%
Q1 24	$7M	0.3%
Q2 24	$7M	1.0%
Q3 24	$6M	0.8%
Q4 24	$8M	0.3%
Q1 25	$7M	0.3%
Q3 25	$2M	0.3%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q3 21	—	—	$262M	—
Q4 21	—	—	$445M	—
Q1 22	—	—	$280M	—
Q2 22	—	—	$453M	—
Q3 22	—	—	$445M	—
Q4 22	—	—	—	$383M
Q1 23	—	—	$449M	—
Q2 23	—	—	$455M	—
Q3 23	—	—	$453M	—
Q4 23	$13M	$1.8B	—	—
Q1 24	—	—	$478M	—
Q2 24	—	—	$469M	—
Q3 24	—	—	$470M	—
Q4 24	—	$101M	—	—
Q1 25	—	—	$462M	—
Q3 25	—	—	—	$266M

Revenue Segments

Quarter	Patient Direct	Products & Healthcare Services
Q1 22	$273M	$2.1B
Q2 22	$573M	$1.9B
Q3 22	$594M	$1.9B
Q4 22	$617M	$1.9B
Q1 23	$607M	$1.9B
Q2 23	$633M	$1.9B
Q1 24	$638M	$2.0B
Q4 24	$695M	$2.0B
Q1 25	$674M	$2.0B

Revenue by Geography

Quarter	Non-US	United States
Q3 21	$121M	$2.4B
Q4 21	$117M	$2.4B
Q1 22	$145M	$2.3B
Q2 22	$123M	$2.4B
Q3 22	$87M	$2.4B
Q4 22	$74M	$2.5B
Q1 23	$70M	$2.5B
Q2 23	$65M	$2.5B
Q3 23	$73M	$2.5B
Q4 23	$68M	$2.6B
Q1 24	$62M	$2.6B
Q4 24	$59M	$2.6B
Q1 25	$51M	$2.6B

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$211M	$0	$211M
Q2 22	$56M	$0	$56M
Q3 22	$77M	$0	$77M
Q4 22	$69M	$0	$69M
Q1 23	$67M	$0	$67M
Q2 23	$286M	$0	$286M
Q3 23	$215M	$0	$215M
Q4 23	$243M	$0	$243M
Q1 24	$245M	$0	$245M
Q2 24	$257M	$0	$257M
Q3 24	$45M	$0	$45M
Q4 24	$49M	$0	$49M
Q1 25	$59M	$0	$59M
Q2 25	$38M	$0	$38M
Q3 25	$33M	$0	$33M
Q4 25	$282M	$0	$282M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	76M	+0.2%	+24.7%
Q4 21	76M	+0.1%	+8.4%
Q1 22	76M	+0.0%	+7.2%
Q2 22	76M	+0.4%	+0.6%
Q3 22	76M	+0.2%	+0.6%
Q4 22	75M	-1.9%	-1.3%
Q1 23	75M	+0.2%	-1.1%
Q2 23	76M	+0.8%	-0.7%
Q3 23	76M	+0.5%	-0.3%
Q4 23	78M	+2.1%	+3.7%
Q1 24	76M	-1.9%	+1.5%
Q2 24	77M	+0.5%	+1.2%
Q3 24	77M	+0.5%	+1.2%
Q4 24	77M	+0.1%	-0.8%
Q1 25	77M	+0.1%	+1.2%
Q3 25	77M	+0.0%	+0.7%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	$397.2K	6K
Q4 21	$357.6K	7K
Q1 22	$348.8K	7K
Q2 22	$362.3K	7K
Q3 22	$361.9K	7K
Q4 22	$190.4K	13K
Q1 23	$188.3K	13K
Q2 23	$191.3K	13K
Q3 23	$193.4K	13K
Q4 23	$193.9K	14K
Q1 24	$190.7K	14K
Q2 24	$48.2K	14K
Q3 24	$50.1K	14K
Q4 24	$199.7K	14K
Q1 25	$195.0K	14K
Q3 25	$51.6K	14K

Revenue / Employee